10.1002/adsc.201701595
Advanced Synthesis & Catalysis
inexpensive and easily available substrates, broad
substrate scope, and good yields. During the course
of the transformations pH of the medium played a
key role toward switching selectivity. Based on our
experimental outcomes, a mechanistic rationale for
this cascade reaction is outlined, which is well
supported and validated by DFT calculations.
Notably, this chemistry is general, mild and low cost,
making this protocol a good alternative to existing
ones. The anti-cancer activity of the prepared
pyrazoles and disulfanes are under investigation in
our lab.
[5] a) M. A. A. El-Sayed, N. I. Abdel-Aziz, A. A. M.
Abdel-Aziz, A. S. El-Azab, K. E. H. ElTahir, Bioorg.
Med. Chem. 2012, 20, 3306; b) A. E. Rashad, M. I.
Hegab, R. E. Abdel-Megeid, J. A. Micky, F. M. E.
Abdel-Megeid, Bioorg. Med. Chem. 2008, 16, 7102.
[6] a) S. H. Hwang, K. M. Wagner, C. Morisseau, J.-Y. Liu,
H. Dong, A. T. Wecksler, B. D. Hammock, J. Med.
Chem. 2011, 54, 3037; b) H.-X. Dai, A. F. Stepan, M. S.
Plummer, Y.-H. Zhang, J.-Q. Yu, J. Am. Chem. Soc.
2011, 133, 7222; c) S. R. Cox, S. P. Lesman, J. F.
Boucher, M. J. Krautmann, B. D. Hummel, M. Savides,
S. Marsh, A. Fielder, M. R. Stegemann, J. Vet.
Pharmacol. Ther. 2010, 33, 461; d) S. R. Cox, S. Liao,
M. Payne-Johnson, R. J. Zielinski, M. R. Stegemann, J.
Vet. Pharmacol. Ther. 2011, 34, 1; e) D. Zhang, N.
Raghavan, S.-Y. Chen, H. Zhang, M. Quan, L.
Lecureux, L. M. Patrone, P. Y. S. Lam, S. J. Bonacorsi,
R. M. Knabb, G. L. Skiles, K. He, Drug Metab. Dispos.
2008, 36, 303; f) P. R. G. Terꢁariol, A. F. Godinho,
Pest. Biochem. Physiol. 2011, 99, 221; g) F. A. Moreira,
J. A. Crippa, Rev. Bras. Psiquiatr. 2009, 2, 145.
[7] a) R. Tripathy, A. Ghose, J. Singh, E. R. Bacon, T. S.
Angeles, S. X. Yang, M. S. Albom, L. D. Aimone, J. L.
Herman, J. P. Mallamo, Bioorg. Med. Chem. Lett. 2007,
17, 1793; b) E. A. Ilardi, E. Vitaku, J. T. Njardarson, J.
Chem. Educ. 2013, 90, 1403.
[8] a) A. Dorlars, C.-W. Schellhammer, J. Schroeder,
Angew. Chem., Int. Ed. 1975, 14, 665; b) J. Catalꢂn, F.
Fabero, R. M. Claramunt, M. D. SantaMaria, M. C.
Foces-Foces, F. Hernꢂndez Cano, M. Martínez-Ripoll,
J. Elguero, R. Sastre, J. Am. Chem. Soc. 1992, 114,
5039; c) T. Karatsu, N. Shiochi, T. Aono, N. Miyagawa,
A. Kitamura, Bull. Chem. Soc. Jpn. 2003, 76, 1227; d)
H. Maeda, Y. Ito, Y. Kusunose, T. Nakanishi, Chem.
Commun. 2007, 1136.
Experimental Section
General procedure for the synthesis of 5-thioalkyl-3-
aryl-1H-pyrazoles (3a-o) and 1,2-bis(3-aryl-1H-pyrazol-
5-yl)disulfane (4a-h).
In a round-bottomed flask -ketodithioesters 1 (1.0 mmol)
and semicarbazide hydrochloride 2 (1.0 mmol) were mixed
and 5 mL of H2O was added and it was heated to 100 °C.
After completion of the reaction (monitored by TLC), the
reaction mixture was cooled to room temperature and more
water (20 mL) was added to the followed by extraction
with ethyl acetate (2 × 10 mL). The combined organic
layer was dried over anhydrous Na2SO4 and evaporated in
vacuum. The crude residue was purified by column
chromatography over silica gel using ethyl acetate/hexane
as eluent to afford pure 5-thioalkyl-3-aryl-1H-pyrazoles 3.
In case of compound 4, in a round-bottomed flask -
ketodithioesters
1
(1.0
mmol),
semicarbazide
hydrochloride 2 (1.0 mmol) and sodium acetate (5.0 mmol)
were mixed and 5 mL of H2O was added and it was heated
to 100 °C. Purification and isolation of 1,2-bis(3-aryl-1H-
pyrazol-5-yl)disulfanes 4 have been done follownig the
same procedure like compound 3.
[9] a) J. Olguín, S. Brooker, Coord. Chem. Rev. 2011, 255,
203; b) A. Schmidt, A. Dreger, Curr. Org. Chem. 2011,
15, 2897; c) V. S. Thirunavukkarasu, K. Raghuvanshi,
L. Ackermann, Org. Lett. 2013, 15, 3286; d) P. M. Liu,
C. G. Frost, Org. Lett. 2013, 15, 5862.
Acknowledgements
The authors gratefully acknowledge the generous financial
support from the Science and Engineering Research Board, New
Delhi (SERB/EMR/2015/002482), the Council of Scientific and
Industrial Research (02(0263)/16/EMR-II), New Delhi, India.
[10] a) S. Fustero, M. Sanchez-Rosello, P. Barrio, A.
Simon-Fuentes, Chem. Rev. 2011, 111, 6984; b) A. V.
Gulevich, A. S. Dudnik, N. Chernyak, V. Gevorgyan,
Chem. Rev. 2013, 113, 3084; c) R. Properzi, E.
Marcantoni, Chem. Soc. Rev. 2014, 43, 779; d) T.
References
[1] a) E. Arbaciauskienꢀ, G. Vilkauskaitꢀ, G. A. Eller, W.
Holzer, A. Sackus, Tetrahedron 2009, 65, 7817; b) J.
Elguero, P. Goya, N. Jagerovic, A. M. S. Silva, In
Pyrazoles as Drugs: Facts and Fantasies in Targets in
Heterocyclic Systems, Vol. 6 (Eds.: O. A. Attanasi, D.
Spinelli), Italian Society of Chemistry, Rome, 2002, pp
52; c) G. K. Gupta, A. Kumar, Acta Poloniae
Pharmaceutica-Drug Research 2012, 69, 763; d) L. L.
Corre, L. Tak-Tak, A. Guillard, G. Prestat, C. Gravier-
Pelletier, P. Busca, Org. Biomol. Chem. 2015, 13, 409.
[2] H. A. Abd El Razik, M. H. Badr, A. H. Atta, S. M.
Mouneir, M. M. Abu-Serie, Arch. Pharm. 2017, 350,
1700026.
Chatterjee, V. S. Shetti, R. Sharma, M.
Ravikanth,
Chem. Rev. 2017, 117, 3254; e) M. Yoshimatsu, K.
Ohta, N. Takahashi, Chem. Eur. J. 2012, 18, 15602; f)
V. Marković, M. D. Joksović, Green Chem. 2015, 17,
842.
[11] a) X. Li, L. He, H. Chen, W. Wu, H. Jiang, J. Org.
Chem. 2013, 78, 3636; b) X. W. Fan, T. Lei, C. Zhou,
Q. Y. Meng, B. Chen, C. H. Tung, L. Z. Wu, J. Org.
Chem. 2016, 81, 7127; c) F. Punner, Y. Sohtome, M.
Sodeoka, Chem. Commun. 2016, 52, 14093.
[12] X.-Q. Hu, J.-R. Chen, Q. Wei, F.-L. Liu, Q.-H. Deng,
A. M. Beauchemin, W.-J. Xiao, Angew. Chem., Int. Ed.
2014, 53, 12163.
[3] A. Schmidt, A. Dreger, Curr. Org. Chem. 2011, 15,
1423.
[4] M. R. Bhosle, J. R. Mali, S. Pal, A. K. Srivastava, R. A.
Mane, Bioorg. Med. Chem. Lett. 2014, 24, 2651.
[13] S. Chen, N. Li, B. Li, Synlett 2016, 1597.
[14] L. Li, P. Liu, Y. Su, H. Huang, Org. Lett. 2016, 18,
5736.
5
This article is protected by copyright. All rights reserved.